• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Protective immunity against avian influenza induced by a fowlpox virus recombinant.

作者信息

Taylor J, Weinberg R, Kawaoka Y, Webster R G, Paoletti E

机构信息

Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany 12201.

出版信息

Vaccine. 1988 Dec;6(6):504-8. doi: 10.1016/0264-410x(88)90101-6.

DOI:10.1016/0264-410x(88)90101-6
PMID:2854339
Abstract

Fowlpox virus, the prototypic virus of the genus Avipoxvirus has a natural host range limited to avian species. As such, fowlpox virus provides a suitable candidate for the development of a species-specific recombinant viral vector. This paper reports the development of a fowlpox virus recombinant expressing the haemagglutinin molecule from a highly virulent avian influenza virus. On immunization of chickens and turkeys with the recombinant, protection is afforded against a lethal challenge with either the homologous or a heterologous influenza virus strain.

摘要

相似文献

1
Protective immunity against avian influenza induced by a fowlpox virus recombinant.
Vaccine. 1988 Dec;6(6):504-8. doi: 10.1016/0264-410x(88)90101-6.
2
Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin.用表达H7血凝素的禽痘重组体对鸡进行禽流感疫苗接种。
Aust Vet J. 2000 Jan;78(1):44-8. doi: 10.1111/j.1751-0813.2000.tb10359.x.
3
Recombinant fowlpox virus inducing protective immunity in non-avian species.
Vaccine. 1988 Dec;6(6):497-503. doi: 10.1016/0264-410x(88)90100-4.
4
Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes.用共表达H5血凝素和N1神经氨酸酶基因的重组鸡痘病毒保护鸡免受高致病性H5N1和H7N1禽流感病毒感染。
Avian Pathol. 2003 Feb;32(1):25-32. doi: 10.1080/0307945021000070688.
5
Immunization of chickens and turkeys against avian influenza with monovalent and polyvalent oil emulsion vaccines.使用单价和多价油乳剂疫苗对鸡和火鸡进行禽流感免疫接种。
Am J Vet Res. 1979 Feb;40(2):165-9.
6
Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine.一种含有禽流感血凝素基因的重组禽痘病毒疫苗,在已用禽痘疫苗进行过预免疫的鸡中,未能提供针对流感的持续保护。
Avian Dis. 2000 Jan-Mar;44(1):132-7.
7
The safe and effective use of fowlpox virus as a vector for poultry vaccines.禽痘病毒作为家禽疫苗载体的安全有效应用。
Dev Biol Stand. 1994;82:137-45.
8
[Construction, genetic stability and protective efficacy of recombinant fowlpox virus expressing hemagglutinin gene of H5N1 subtype avian influenza virus].[表达H5N1亚型禽流感病毒血凝素基因的重组鸡痘病毒的构建、遗传稳定性及免疫保护效力]
Wei Sheng Wu Xue Bao. 2003 Dec;43(6):722-7.
9
Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens.
Vaccine. 1991 May;9(5):303-8. doi: 10.1016/0264-410x(91)90055-b.
10
Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses.重组禽痘病毒对鸡的高致病性禽流感病毒(H5N2)的保护作用。
Avian Dis. 1991 Apr-Jun;35(2):356-9.

引用本文的文献

1
Current Status of Poultry Recombinant Virus Vector Vaccine Development.家禽重组病毒载体疫苗的研发现状
Vaccines (Basel). 2024 Jun 6;12(6):630. doi: 10.3390/vaccines12060630.
2
Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platform.使用合成痘苗病毒安卡拉(MVA)平台开发的高度稳定且具有免疫原性的巨细胞病毒(CMV)T细胞候选疫苗。
NPJ Vaccines. 2024 Mar 30;9(1):68. doi: 10.1038/s41541-024-00859-3.
3
Capripoxviruses, leporipoxviruses, and orthopoxviruses: Occurrences of recombination.山羊痘病毒、兔痘病毒和正痘病毒:重组的发生情况。
Front Microbiol. 2022 Oct 6;13:978829. doi: 10.3389/fmicb.2022.978829. eCollection 2022.
4
Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19.基于病毒载体的 COVID-19 预防用潜在候选疫苗的研发前景
Front Mol Biosci. 2021 Apr 15;8:635337. doi: 10.3389/fmolb.2021.635337. eCollection 2021.
5
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform.使用合成痘病毒平台开发多抗原 SARS-CoV-2 疫苗候选物。
Nat Commun. 2020 Nov 30;11(1):6121. doi: 10.1038/s41467-020-19819-1.
6
AIV polyantigen epitope expressed by recombinant baculovirus induces a systemic immune response in chicken and mouse models.重组杆状病毒表达的 AIV 多抗原表位在鸡和鼠模型中诱导全身性免疫应答。
Virol J. 2020 Aug 5;17(1):121. doi: 10.1186/s12985-020-01388-w.
7
Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform.使用合成痘病毒平台开发多抗原性SARS-CoV-2疫苗。
Res Sq. 2020 Jul 17:rs.3.rs-40198. doi: 10.21203/rs.3.rs-40198/v1.
8
Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine.基于合成痘病毒的新型冠状病毒 2 型疫苗的研发
bioRxiv. 2020 Jul 2:2020.07.01.183236. doi: 10.1101/2020.07.01.183236.
9
Viral vector-based influenza vaccines.基于病毒载体的流感疫苗。
Hum Vaccin Immunother. 2016 Nov;12(11):2881-2901. doi: 10.1080/21645515.2016.1210729. Epub 2016 Jul 25.
10
The evolution of poxvirus vaccines.痘病毒疫苗的演变
Viruses. 2015 Apr 7;7(4):1726-803. doi: 10.3390/v7041726.